LIDOCAINE PAIN RELIEF- lidocaine pain relief patch 
PAI Holdings, LLC

----------

Maximum Strength

Lidocaine Pain Relief Patch

4% Lidocaine ι Topical Anesthetic

Active ingredient(s)

Lidocaine 4%

Purpose

Topical anesthetic

Uses

Temporary relief of pain

Warnings

For external use only

Do not use

  • more than one patch at a time
  • on wounds or damaged, broken or irritated skin
  • if you are allergic to any ingredients of this product

When using this product

  • use only as directed          • read and follow all directions and warnings
  • do not allow contact with eyes and mucous membranes
  • do not bandage tightly      • do not apply local heat such as a heating pad
  • do not use other topical anesthetics at the same time

Stop use and ask a doctor if

  • localized skin reactions occur, such as rash, itching, redness, irritation,
    pain, swelling and blistering
  • conditions worsen
  • symptoms persist for more than 7 days
  • symptoms clear up and occur again within a few days

if pregnant or breast-feeding, 

ask a healthcare professional before use.

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Adults and children over 12 years:

Children under 12 years of age: consult a doctor

Inactive ingredients

dihydroxyaluminum aminoacetate, disodium edetate, gelatin, glycerin, kaolin, methylparaben, polyacrylic acid, polyvinyl
alcohol, propylene glycol, propylparaben, sodium carboxymethylcellulose, sodium polyacrylate, D-sorbitol, tartaric acid, urea, water

Comments or Questions:

1-800-845-8210

††This product is not manufactured or distributed by Chattem, Inc., distributor of Aspercreme® Lidocaine Patch.

Distributed by

PAI LOGO

 MADE IN JAPAN

C09750050222 R02/22

Principal Display Panel

lidocaine-patch

lidocaine patch


LIDOCAINE PAIN RELIEF 
lidocaine pain relief patch
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0121-0970
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE560 mg
Inactive Ingredients
Ingredient NameStrength
DIHYDROXYALUMINUM AMINOACETATE (UNII: DO250MG0W6)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
GELATIN (UNII: 2G86QN327L)  
GLYCERIN (UNII: PDC6A3C0OX)  
KAOLIN (UNII: 24H4NWX5CO)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
POLYACRYLIC ACID (250000 MW) (UNII: 9G2MAD7J6W)  
POLYVINYL ALCOHOL (100000 MW) (UNII: 949E52Z6MY)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED (UNII: K679OBS311)  
SODIUM POLYACRYLATE (2500000 MW) (UNII: 05I15JNI2J)  
SORBITOL (UNII: 506T60A25R)  
TARTARIC ACID (UNII: W4888I119H)  
UREA (UNII: 8W8T17847W)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0121-0970-0512 in 1 CASE04/03/2023
15 in 1 CARTON
1NDC:0121-0970-011 in 1 POUCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph Drug505G(a)(3)04/03/2023
Labeler - PAI Holdings, LLC (044940096)

Revised: 11/2023
Document Id: 66f585b5-28c3-4e0b-a631-a8c65bda0324
Set id: 963978de-8295-47ee-9b06-64c3521aa994
Version: 4
Effective Time: 20231120
 
PAI Holdings, LLC